Aggression aimed at oneself in cases of mental disorders comorbid with abuse of synthetic cannabinoids (spices)
Suggested citation:
Bokhan NA, Selivanov GYu. [Aggression aimed at oneself in cases of mental disorders comorbid with abuse of synthetic cannabinoids (spices)]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2023;(3):76-90. Russian
In this prospective controlled study, 117 men (F60.xx–F62.xx (n=66); F20.xx (n=51)), addicted to drugs, were examined in order to study the phenomenon of aggression aimed at oneself and identifying the distinctive features of suicide and accident in people suffering from mental disorders and abusing synthetic cannabinoids (F12.2). Variants of aggression aimed at oneself, depending on the state caused by drugs have been highlighted: 1) in episodes of exacerbations (F60.xx–F62.xx (n=35); F20.xx (n=43)) caused by hallucinations (F60.xx–F62.xx (n=17), F20.xx (n=20)), delusions (F60.xx–F62.xx (n=6), F20.xx (n=8)), delirium (F60.xx–F62.xx (n=12), F20.xx (n=15)); 2) in episodes of remission (F60.xx–F62.xx (n=31); F20.xx (n=8)) due to symptoms of depression (F60.xx–F62.xx (n=26), F20.xx (n=6)), dysphoria (F60.xx–F62.xx (n=5), F20.xx (n=4)). It is concluded that drug abuse can initiate aggression aimed at oneself mainly in persons with personality disorders and, to a lesser extent, in patients with schizophrenia. Genuine suicides in drug users include exclusively episodes with depressive symptoms that differ from accidents in such features as symptoms of drug abuse, asthenic-depressive symptoms that develop within 3–4 days against the background of drug withdrawal, obsessive suicidal ideation, cumulating the growth of anxiety and sleep disorders, social isolation for 3 days, a history of suicide episodes over the past year.
Keywords suicide; aggression aimed at oneself; synthetic cannabinoids; addiction; abuse; schizophrenia; personality disorders; comorbidity
1. Bokhan NA, Selivanov GYu, Lavrova UA, et al. [Clinical typology of negative (deficit) symptoms in patients with paranoid schizophrenia dependent on synthetic cannabinoids (spice)]. Sibirskij vestnik psihiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2019;4(105):34–44. (In Russ.) DOI: https://doi.org/10.26617/1810-3111-2019-4(105)-27-37 2. Bokhan NA, Selivanov GYu, Salnikov AA, et al. [Mental Disorders Associated with the Abuse of Synthetic Cannabinoids (Spices)]. Psihiatrija [Psychiatry]. 2021;19(2):6–16. (In Russ.) DOI: https://doi.org/10.30629/2618-6667-2021-19-2-6-16 3. Klimova IYu, Ovchinnikov AA, Karpushkin AM. [Clinical features of paranoid schizophrenia, comorbid with a syndrome of dependence on the use of cannabinoids]. Sibirskij vestnik psihiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2020;2(107):34–40. (In Russ.) DOI: https://doi.org/10.26617/1810-3111-2020-2(107)-34-40 4. Bokhan NA, Selivanov GYu, Mandel AI, et al. [Clinical typology of withdrawal syndrome in dependence on synthetic cannabinoids (spice) in patients with paranoid schizophrenia]. Sibirskij vestnik psihiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2019;1(102):62–70. (In Russ.) DOI: https://doi.org/10.26617/1810-3111-2019-1(102)-62-70 5. Bokhan NA, Selivanov GYu, Salnikov AA, et al. [Withdrawal syndrome in synthetic cannabinoid dependence associated with mental disorders]. Voprosy narkologii [Journal of Addiction Problems]. 2020;12(195):5–18. (In Russ.) DOI: https://doi.org/10.47877/0234-0623_2020_12_5 6. Klimova IYu, Ovchinnikov AA, Karpushkin AM. [Cannabinoid addiction syndrome as risk factor of development of paranoid schizophrenia (clinical and dynamical features of paranoid schizophrenia)]. Sibirskij medicinskij vestnik [Siberian Medical Bulletin]. 2018;2(3):19–23. (In Russ.) 7. Klimenko TV, Shakhova SM, Kozlov AA. [Psychotic disorders due to use of synthetic cannabinoids (spice)]. Sibirskij vestnik psihiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2017;2(95):26–30. (In Russ.) 8. Henderson DC, Vincenzi B, Andrea NV, et al. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry. 2015;2(5):452–64. DOI: https://doi.org/10.1016/S2215-0366(15)00115-7 9. Canal-Rivero M, López-Moríñigo JD, Setién-Suero E, et al. Predicting suicidal behaviour after first episode of non-affective psychosis: The role of neurocognitive functioning. Eur Psychiatry. 2018;53:52–7. DOI: https://doi.org/10.1016/j.eurpsy.2018.06.001 10. Kornetova EG, Mikilev FF, Semke AV, et al. [Ways to improve rehabilitation tactics in schizophrenia with the risk of developing a negative symptom complex]. Sibirskij vestnik psihiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2016;3(92):9–13. (In Russ.) 11. Kornetova EG, Goncharova AA, Kornetov AN, et al. [Сonnection of suicidal behavior and hopelessness with akathisia in patients with schizophrenia]. Suitsidologiya [Suicidology]. 2018;9(3):63–70. (In Russ.) DOI: https://doi.org/10.32878/suiciderus.18-09-03(32)-63-70 12. Bokhan NA, Selivanov GYu, Blonsky KA. [Preventive emergency therapy for psychiatric disorders comorbid with synthetic cannabinoid abuse]. Narkologia [Narcology]. 2022;21(5):16–24. (In Russ.) DOI: https://doi.org/10.25557/1682-8313.2022.05.16-24 13. Ivanets NN, Vinnikova MA, Ezhkova EV, et al. [Clinical presentations and therapy of polysubstance dependence in patients with schizophrenia]. Zh Nevrol Psikhiatr Im SS Korsakova. 2021;121(4):63–9. (In Russ.) DOI: https://doi.org/10.17116/jnevro202112104163 14. Klimova IY, Ovchinnikov AA, Karpushkin AM. [Identification of the level of depressive state and evaluation of risk for suicidal behavior in patients with schizophrenia with comorbid cannabinoid dependence, having formed before the manifestation of schizophrenia]. Sibirskij vestnik psihiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2019;4(105):67–73. (In Russ.) DOI: https://doi.org/10.26617/1810-3111-2019-4(105)-67-73 15. Dmitrieva EG, Danilenko OA, Kornetova EG, et al. [Influence of compliance on adaptation of schizophrenic patients]. Sibirskij vestnik psihiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2014;3(84):18–23. (In Russ.) 16. Lyubov EB, Tsuprun VE. [Suicidal behaviour and schizophrenia: promising preventative and curative biopsychosocial interventions]. Suitsidologiya [Suicidology]. 2013;4(3):3–16. (In Russ.) 17. Kornetova EG, Dmitrieva ЕG, Dubrovskaya VV, et al. [Suicidal behavior in patients with schizophrenia with metabolic syndrome]. Suitsidologiya [Suicidology]. 2019;10(2):92–8. (In Russ.) DOI: https://doi.org/10.32878/suiciderus.19-10-02(35)-92-98 18. Selivanov GY, Bokhan NA. Psycho-social adaptation in patients with paranoid schizophrenia addicted to synthetic cannabinoids (spice). JCD. 2021. URL: https://cdspress.ca/wp-content/uploads/2022/03/Selivanov_MS_NB05_FINAL_JULY16.pdf (accessed on: 07.04.2023). 19. Bokhan NA, Selivanov GYu, Blonsky KA, et al. [Features of socio-psychological adaptation of patients with paranoid form of schizophrenia complicated by synthetic cannabinoids (spice) dependence]. Sibirskii vestnik psikhiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2018;2(99):93–8. (In Russ.) DOI: https://doi.org/10.26617/1810-3111-2018-2(99)-93-98 20. Klimova IYu, Ovchinnikov AA, Karpushkin AM. [Remission with paranoid schizophrenia associated with cannabinoid use disorder]. Sibirskij medicinskij vestnik [Siberian Medical Bulletin]. 2019;3(1):15–20. (In Russ.) 21. Kekelidze ZI, Polozhy BS, Boyko EO, et al. [Suicide during the pandemic self-isolation]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2020;(3):4–13. (In Russ.) DOI: https://doi.org/10.24411/1560-957X-2020-10301 22. Bokhan NA, Selivanov GYu. [Rehabilitation in addictive psychotherapeutic communities of mental patients with comorbid abuse of synthetic cannabinoids]. Sibirskii vestnik psikhiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2022;2(115):48–56. (In Russ.) DOI: https://doi.org/10.26617/1810-3111-2022-2(115)-48-56 23. Selivanov GYu, Bokhan NA, Serazetdinova LG. [Rehabilitation with psychotherapy in addictive communities of mental patients with comorbid abuse of synthetic cannabinoids]. Narkologia [Narcology]. 2022;21(10):31–9. (In Russ.) DOI: https://doi.org/10.25557/1682-8313.2022.10.31-39
Article Metrics
Metrics powered by PLOS ALM